Review Article
Evaluation of Fluid Responsiveness: Is Photoplethysmography a Noninvasive Alternative?
Table 1
Papers in which ΔPOP and/or PVI have been evaluated and fluid challenges performed.
| Author, Ref. | Fluid challenge | CO/CI/SVI measurement | Responder | ROC | Threshold value | Sens/spec |
| Solus-Biguenet et al. [21] | 250 mL colloid | Thermodilution | SVI: 10% | 0.81 | PPVfina: 14% | No data | | | | | 0.68 | ΔPOP: 9.5% | No data | | | | | 0.79 | PPVart: 12.5% | No data | Natalini et al. [22] | 500 mL HES 6% | Thermodilution | CI: 15% | 0.72 | ΔPOP: 15% | 56/86 (PPV/NPV) | | | | | 0.74 | ΔPP: 15% | 55/100 (PPV/NPV) | Cannesson et al. [23] | 500 mL HES 6% | Thermodilution | CI: 15% | 0.847 | ΔPOP: 13% | 93/90 | | | | | 0.847 | ΔPP: 11% | 80/90 | Feissel et al. [24] | 8 mL/kg HES 6% | Echo-Doppler | CI: 15% | 0.94 | ΔPP: 12% | 100/70 | | | | | 0.94 | ΔPOP: 14% | 94/80 | Wyffels et al. [25] | 500 mL HES 6% | Intermittent thermodilution | CO: 15% | 0.94 | PPV: 11.3% | 95/91.7 | | | by pulm. artery catheter | | 0.89 | ΔPOP: 11.3% | 90/83.3 | Cannesson et al. [26] | 500 mL HES 6% | Thermodilution | CI: 15% | 0.94 | ΔPP: 12.5% | 87/89 | | | | | 0.94 | ΔPOP: 12% | 87/89 | | | | | 0.93 | PVI: 14% | 81/100 | Westphal et al. [27] | 500–1000 mL NaCl | Not measured | ΔPP > 13% | 0.95 | ΔPOP: 11% | 91/100 | Zimmermann et al. [28] | 7 mL/kg HES 6% | FloTrac | SVI: 15% | 0.97 | PVI: 9.5 % | 93/100 | Loupec et al. [29] | 500 mL HES | Echocardiography | CO: 15% | 0.88 | PVI: 17% | 95/91 | | or PLR if ΔPP < 13% | | | | | | Desgranges et al. [30] | 500 mL HES | Thermodilution | CI: 15% | 0.91 | PVIforehead : 15% | 89/78 | | | | | 0.88 | PVIear: 16% | 74/74 | | | | | 0.84 | PVIfinger : 12% | 74/67 | | | | | 0.84 | PPV > 11% | 74/89 | | | | | | PVIforehead : 15% | 89/100 | | | | | | and PIforehead : 1.37 | | Renner et al. [31] | HES 10 mL kg−1 | Transoesophageal echocardiography | SVI: 15% | 0.79 | PVI > 13% | 84/64 | De Souza Neto et al. [32] | Saline, 20 mL/kg | Transthoracic echography | AVTI: 15% | 0.51 | 0–6 yr: ΔPOP | No data | | | (aortic velocity-time integral) | | 0.63 | 0–6 yr: PVI | No data | | | | | 0.71 | 0–6 yr: ΔPP | No data | | | | | 0.52 | 0–6 yr: PPV | No data | | | | | 0.57 | 6–14 yr: ΔPOP | No data | | | | | 0.54 | 6–14 yr: PVI | No data | | | | | 0.60 | 6–14 yr: ΔPP | No data | | | | | 0.60 | 6–14 yr: PPV | No data | Hoiseth et al. [33] | 250 mL colloid | Esophageal doppler | SV ≥ 15% | 0.67 | ΔPP: 8.8% | 82/67 | | | | | 0.72 | ΔPOP: 11.4% | 86/67 | Hood and wilson [34] | 500 mL colloid | Esophageal doppler | SV ≥ 10% | 0.96 | PVIfinger (baseline) 10% | 86/100 | | | | | 0.98 | PVIearlobe (baseline) 9.5% | 95/100 | | | | | 0.71 | PVIfinger (during surgery) 10% | 65/67 | | | | | 0.54 | PVIearlobe (during surgery) | |
|
|
ΔPOP: pulse oximetry plethysmography; ΔPP: pulse pressure; PVI: Pleth variability index; CI: cardiac index; SV: stroke volume; SVI: stroke volume index; SVV: stroke volume variation; CO: cardiac output; PPVfina: pulse pressure variation obtained with Finapres; PPVart: pulse pressure variation obtained with intraarterial equipment; PPV/NPV: positive predictive value/negative predictive value.
|